Skip to content
Clinical Trials – home

Disodium Folinate: A Comprehensive Guide for Patients

4 / 7
trials open to patients / all trials
13+
Countries

In short

Disodium folinate, also known as sodium folinate or leucovorin calcium, is being studied in several clinical trials for its potential role in cancer treatment, particularly in combination with other chemotherapy drugs. This article explores the use of disodium folinate in ongoing clinical trials for various types of cancer, including colorectal, esophagogastric, and other advanced cancers.

What is Disodium Folinate?

Disodium folinate, also known as sodium folinate or leucovorin, is a medication used in cancer treatment and to counteract the toxic effects of certain chemotherapy drugs. It is a form of folic acid that can be easily used by the body. Disodium folinate is typically administered as a solution for injection or infusion.

Medical Uses

Disodium folinate is primarily used in the treatment of colorectal cancer, often in combination with other chemotherapy drugs. It has several important applications:

  • Enhancing the effectiveness of chemotherapy drugs like fluorouracil (5-FU)
  • Reducing the toxic side effects of certain chemotherapy medications
  • Treating folate deficiency in some patients
  • As part of combination therapies for advanced colorectal cancer

How It Works

Disodium folinate works by providing an active form of folic acid to cells. In cancer treatment, it helps to:

  • Enhance the effect of fluorouracil (5-FU) on cancer cells
  • Protect healthy cells from the toxic effects of certain chemotherapy drugs
  • Support the body's production of healthy blood cells

Administration

Disodium folinate is typically administered intravenously (through a vein) in a hospital or clinic setting. It is often given as part of a chemotherapy regimen, such as FOLFIRI (a combination of folinic acid, fluorouracil, and irinotecan) or FOLFOX (folinic acid, fluorouracil, and oxaliplatin).

Dosage

The dosage of disodium folinate can vary depending on the specific treatment regimen and the patient's individual needs. In clinical trials, doses have ranged from 200 to 500 mg/m² (milligrams per square meter of body surface area). However, the exact dosage should always be determined by a healthcare professional.

Side Effects

While disodium folinate is generally well-tolerated, some patients may experience side effects. Common side effects may include:

  • Nausea
  • Vomiting
  • Diarrhea
  • Fatigue
  • Mouth sores

It's important to note that many side effects experienced during treatment may be due to the chemotherapy drugs used in combination with disodium folinate, rather than disodium folinate itself.

Precautions

Patients should inform their healthcare provider about any allergies, medical conditions, or medications they are taking before starting treatment with disodium folinate. Special precautions may be necessary for patients with:

  • Kidney problems
  • Liver disease
  • History of seizures
  • Pregnancy or breastfeeding

Additionally, patients with a known deficiency of an enzyme called dihydropyrimidine dehydrogenase (DPD) may require dose adjustments or alternative treatments.

Ongoing Research

Disodium folinate continues to be studied in various clinical trials, particularly in combination with other cancer treatments. Current research is exploring its use in:

  • Improving outcomes for patients with metastatic colorectal cancer
  • Enhancing the effectiveness of chemotherapy regimens like FOLFIRI and FOLFOX
  • Investigating its role in perioperative treatment (treatment before and after surgery) for localized gastroesophageal cancer

These ongoing studies aim to optimize treatment strategies and improve patient outcomes in various types of cancer, particularly colorectal and gastroesophageal cancers.

Questions people often ask

Conditions where Disodium Folinate is being studied

Each condition opens its own overview and trial list

Trials with Disodium Folinate

Recruiting trials first

See all 7 →
Quick filters
  • Participants:Adults
  • Participants:Adults
  • Participants:Adults
  • Participants:Adults
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).